Novonesis sales grow more than expected in third quarter
Nov 6 (Reuters) - Danish biosolutions company Novonesis NSISb.CO on Thursday reported stronger-than-expected organic sales growth in the third quarter, and narrowed its guidance for the full year. (Reporting by Izabela Niemiec and Elviira Luoma in Gdansk, editing by Matt Scuffham) ((izabela.niemiec@thomsonreuters.com, elviira.luoma@thomsonreuters.com))
Recent news on Novozymes A/S
See all newsGivaudan jumps on fragrance outperformance; peers follow
Europe Research Roundup: IWG, Londonmetric, Sartorius
Brief: Novonesis To Build Next Generation Enzyme Production Facility In India
Next cycle in ingredient makers sector belongs to biotech, Jefferies says
Europe Research Roundup: DSM-Firmenich, Merck, Orsted